Treating Gastrointestinal and Autism Symptoms in Adults with Autism Using Microbiota Transfer Therapy (MTT)

Abstract

The purpose of this study is to determine the safety and efficacy of Microbiota Transfer Therapy for adults with autism and chronic gastrointestinal problems.Scope: The scope of the project is a randomized, double-blind, placebo-controlled trial ofMTT for 84 adults with autism. The trial also includes an extension, partial cross-over, and long-term follow-up (6, 12, and 18 months). It includes extensive evaluation of autism related and gastrointestinal symptoms, evaluation of microbiome composition, and blood safety tests. It includes 84 neurotypical controls (half with GI symptoms, half without) for comparison of baseline microbiota (no treatment for the neurotypical group).

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Dec 01, 2022
Accession Number
AD1196247

Entities

People

  • James B. Adams

Organizations

  • Arizona State University

Tags

Communities of Interest

  • Biomedical

DTIC Thesaurus Topics

  • Abstracts
  • Biomedical Research
  • Clinical Trials
  • Covid-19
  • Department Of Defense
  • Medical Personnel
  • Microbiomes
  • Monitoring
  • Patent Applications
  • Personnel Management
  • Physicians
  • Professional Development
  • Research Facilities
  • Sars
  • Standards
  • Technology Transfer
  • Test And Evaluation
  • Therapy
  • Universities
  • Urban Areas
  • Viruses

Readers

  • Child and Adolescent Substance Abuse Science in Autism Spectrum Disorders.
  • Criminal Law
  • Trauma Surgery or Emergency Medicine.